Proprio key facts
- Developer of a surgical technology company designed to improve surgical accuracy, simplify surgical workflows, and enhance patient outcomes.
- Proprio’s last known valuation is $145.0M.
- It has raised $81.8M across 2 recorded rounds; the latest was Debt ($5.0M) in Jul 2021.
- Notable investors include Nvidia, DCVC, Intel Capital, Acequia Capital, Trousdale Ventures — 24 tracked in total.
- Proprio has filed 3 Form Ds with the SEC since 2020, most recently Jul 2021 ($5.0M sold to 2 investors).
- Status: Privately Held (backing).
Who backs Proprio
24+Membership and data by Private Market View
- ·The complete investor list: 24 names
- ·Watch Proprio: the Monday email on marks, rounds and moves
Proprio funding rounds
2 roundsProprio valuation
Proprio's last known valuation is $145 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Proprio raised?
Proprio has raised $81.8 million in total; 2 of its rounds are on record. The largest on record was a $5 million debt round in Jul 2021.
Proprio has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2021 ($5 million sold to 2 investors).
Proprio investors
24 investors are on record for Proprio, including Nvidia, DCVC, Intel Capital and Acequia Capital. By type, the record holds 6 venture capital firms and 1 family office. The debt round in Jul 2021 drew 2 investors.
About Proprio
Developer of a surgical technology company designed to improve surgical accuracy, simplify surgical workflows, and enhance patient outcomes. The company uses advancements in light field computer vision and artificial intelligence (AI) and synthesizes data from multiple inputs for navigating anatomy and surgical environments in a three-dimensional (3D) environment, helping medical professionals to improve clinical and economic outcomes by leveraging advanced artificial intelligence (AI) and data collection capabilities with the potential to provide predictive intelligence in surgery.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2016
- Employees
- 40
- Website
- propriovision.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Proprio’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.